Raleigh Radiology is now facing a lawsuit related to the suspension of its mammography services last month by the American College of Radiology (ACR) and the U.S. Food and Drug Administration (FDA).
The lawsuit against Raleigh Radiology Blue Ridge was filed on December 31, 2019, on behalf of Emily Cram and other plaintiffs who allege that the facility's promotion of having the "most advanced mammography technology available" and the availability of digital mammography screening is, in the words of the lawsuit, "incorrect" and failed to "provide the promised breast cancer screenings" for patients who were screened between November 7, 2017, and November 6, 2019.
A statement from officials of the North Carolina facility, issued last month, said they expect the suspension to be temporary, and the ACR assessment covered a "small number of mammography cases and only as to the technical quality of the mammography images generated." They noted that the "majority of the cases reviewed were acceptable to the ACR and neither the ACR nor the FDA has indicated that any visible cancer or disease on any image was overlooked."
Blue Ridge must implement a corrective action plan before the ACR and FDA can reinstate its mammography services. Blue Ridge's other imaging services remain available.
All other Raleigh Radiology facilities continue to operate and are not affected by the temporary mammography suspension.
